Header Logo

Connection

Jessica Chubak to Early Detection of Cancer

This is a "connection" page, showing publications Jessica Chubak has written about Early Detection of Cancer.
Connection Strength

4.558
  1. Positive predictive value of cervical cancer screening results recommended for colposcopy by human papillomavirus vaccination status at 3 U.S. healthcare systems. Cancer Causes Control. 2025 Nov; 36(11):1549-1561.
    View in: PubMed
    Score: 0.657
  2. Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment Interval. Cancer Epidemiol Biomarkers Prev. 2022 08 02; 31(8):1517-1520.
    View in: PubMed
    Score: 0.533
  3. Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System. J Clin Gastroenterol. 2017 Aug; 51(7):650-655.
    View in: PubMed
    Score: 0.377
  4. Defining and measuring adherence to cancer screening. J Med Screen. 2016 12; 23(4):179-185.
    View in: PubMed
    Score: 0.342
  5. Assessing the effectiveness of a cancer screening test in the presence of another screening modality. J Med Screen. 2015 Jun; 22(2):69-75.
    View in: PubMed
    Score: 0.314
  6. Uptake and positive predictive value of fecal occult blood tests: A randomized controlled trial. Prev Med. 2013 Nov; 57(5):671-8.
    View in: PubMed
    Score: 0.288
  7. Optimal Stopping Ages for Colorectal Cancer Screening. JAMA Netw Open. 2024 Dec 02; 7(12):e2451715.
    View in: PubMed
    Score: 0.157
  8. Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning Ten Years after a Negative Colonoscopy, among Screen-Eligible Adults 76 to 85 Years Old. Cancer Epidemiol Biomarkers Prev. 2023 01 09; 32(1):37-45.
    View in: PubMed
    Score: 0.137
  9. Association of Physician Adenoma Detection Rates With Postcolonoscopy Colorectal Cancer. JAMA. 2022 06 07; 327(21):2114-2122.
    View in: PubMed
    Score: 0.132
  10. Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium. J Natl Cancer Inst. 2020 03 01; 112(3):238-246.
    View in: PubMed
    Score: 0.113
  11. Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population. Gastroenterology. 2020 03; 158(4):884-894.e5.
    View in: PubMed
    Score: 0.110
  12. Financial Incentives to Increase Colorectal Cancer Screening Uptake and Decrease Disparities: A Randomized Clinical Trial. JAMA Netw Open. 2019 07 03; 2(7):e196570.
    View in: PubMed
    Score: 0.108
  13. A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial. Cancer. 2017 Nov 15; 123(22):4472-4480.
    View in: PubMed
    Score: 0.094
  14. Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly. Am J Prev Med. 2016 09; 51(3):e67-75.
    View in: PubMed
    Score: 0.087
  15. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach. J Gen Intern Med. 2016 10; 31(10):1190-7.
    View in: PubMed
    Score: 0.087
  16. Colorectal Cancer Screening Rates Increased after Exposure to the Patient-Centered Medical Home (PCMH). J Am Board Fam Med. 2016 Mar-Apr; 29(2):191-200.
    View in: PubMed
    Score: 0.085
  17. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial. Cancer. 2016 Jan 15; 122(2):312-21.
    View in: PubMed
    Score: 0.083
  18. An economic evaluation of colorectal cancer screening in primary care practice. Am J Prev Med. 2015 Jun; 48(6):714-21.
    View in: PubMed
    Score: 0.081
  19. Longitudinal predictors of colorectal cancer screening among participants in a randomized controlled trial. Prev Med. 2014 Sep; 66:123-30.
    View in: PubMed
    Score: 0.076
  20. The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1147-58.
    View in: PubMed
    Score: 0.076
  21. Time to screening in the systems of support to increase colorectal cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2014 Aug; 23(8):1683-8.
    View in: PubMed
    Score: 0.076
  22. Patterns of colorectal cancer screening uptake in newly eligible men and women. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1230-7.
    View in: PubMed
    Score: 0.075
  23. Psychological distress after a positive fecal occult blood test result among members of an integrated healthcare delivery system. Cancer Epidemiol Biomarkers Prev. 2014 Jan; 23(1):154-9.
    View in: PubMed
    Score: 0.073
  24. An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med. 2013 Mar 05; 158(5 Pt 1):301-11.
    View in: PubMed
    Score: 0.069
  25. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med. 2013 Mar 05; 158(5 Pt 1):312-20.
    View in: PubMed
    Score: 0.069
  26. Delivering Guideline-Concordant Care for Patients With High-Risk HPV and Normal Cytologic Findings. JAMA Netw Open. 2025 Jan 02; 8(1):e2454969.
    View in: PubMed
    Score: 0.039
  27. Evaluating Different Approaches for Calculating Adenoma Detection Rate: Is Screening Colonoscopy the Gold Standard? Gastroenterology. 2023 09; 165(3):784-787.e4.
    View in: PubMed
    Score: 0.035
  28. Factors associated with timely colposcopy following an abnormal cervical cancer test result. Prev Med. 2022 11; 164:107307.
    View in: PubMed
    Score: 0.034
  29. Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines. Ann Intern Med. 2022 11; 175(11):1582-1590.
    View in: PubMed
    Score: 0.034
  30. Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings. Cancer Med. 2023 Feb; 12(3):3705-3717.
    View in: PubMed
    Score: 0.034
  31. Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda. Cancer Epidemiol Biomarkers Prev. 2022 08 02; 31(8):1521-1531.
    View in: PubMed
    Score: 0.033
  32. The association between colorectal sessile serrated adenomas/polyps and subsequent advanced colorectal neoplasia. Cancer Causes Control. 2019 Sep; 30(9):979-987.
    View in: PubMed
    Score: 0.027
  33. Statistical Methods for Estimating the Cumulative Risk of Screening Mammography Outcomes. Cancer Epidemiol Biomarkers Prev. 2016 Mar; 25(3):513-20.
    View in: PubMed
    Score: 0.021

© 2025 Kaiser Permanente

Your Privacy Choices